Relations concentration-effet d'un inhibiteur des récepteurs de type I de l'angiotensine II après administration chez des sujets volontaires sains

PARIS-BIUP (751062107) / SudocSudocFranceF

Anémie et cancer (quelles perspectives d'amélioration de la prise en charge du patient résistant à l'érythropoïétine ?)

PARIS-BIUP (751062107) / SudocSudocFranceF

Onco-Nephrology: Core Curriculum 2015

The overlap between oncology and nephrology is an area of growing importance. A major reason for this is that less than half the patients with cancer were long-term survivors years ago, whereas now more than two-thirds will live 5 years or longer. Late effects of cancer treatment include nephrotoxicity and are part of current clinical practice. In addition, cancer is now a known feature of chronic kidney disease (CKD), with increased risk in patients receiving dialysis or with a functioning kidney transplant, as well as those with earlier stages of the disease. Therefore, oncologists will refer patients to nephrologists, and nephrologists will need to consult oncologists. This Core Curriculum addresses the key issues at this challenging clinical interface